dPCR and qPCR Market is expected to reach US$ 6,371.6 Mn in 2025 With Abbott, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., QIAGEN, TaKARA BIO, INC, Agilent Technologies, Inc., bioMérieux SA, Danaher, Fluidigm Corp

According to The Insight Partners market research study titled ‘dPCR and qPCR Market to 2025 - Global Analysis and Forecasts by Technology, Product, and Application. The global dPCR and qPCR market is expected to reach US$ 6,371.6 Mn in 2025 from US$ 3,255.5 in 2017. The market is estimated to grow with a CAGR of 9.1% from 2018-2025. The report highlights the trends prevalent in the global dPCR and qPCR market and the factors driving the market along with those that act as deterrents to its growth.

For sample report click: https://www.theinsightpartners.com/sample/TIPHE100000817/?openpr-10225

Global dPCR and qPCR market, based on technology was segmented into digital PCR (dPCR) and quantitative PCR (qPCR). In 2017, quantitative PCR (qPCR) segment held the largest share of the market, by technology. The largest share of the quantitative PCR is primariliy owing to its ability to give valuable quantitative data analysis of nucleic acids which is highly specific, sensitive, and accurate. However, the digital PCR (dPCR) segment is expected to grow at the fastest rate during the coming years.

The market for dPCR and qPCR is expected to grow as increasing incidence of genetic diseases, growth in investments & funds for gene synthesis, increasing number of start-up companies and technological developments in PCR technologies are expected to fuel the market growth during the forecast period. In addition, the rapidly developing technologies of dPCR and qPCR and increasing ddPCR technology applications are likely to have a positive impact on the growth of the market in the coming years.

The major players operating in the dPCR and qPCR market Abbott, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., QIAGEN, TaKARA BIO, INC, Agilent Technologies, Inc., bioMérieux SA, Danaher, Fluidigm Corporation. For instance, in June 2018, Qiagen launched QIAseq 16S/ITS Panels and UCP Multiplex PCR Kit with a new generation of reagents to enable the most accurate microbial community profiling from complex microbiome samples.

The report segments the global dPCR and qPCR market as follows:

By Technology

Digital PCR (dPCR)
Quantitative PCR (qPCR)

By Product

Reagents & Consumables
Instruments
Software and Services

By Application

Clinical Application
Pathogen Testing
Oncology Testing
Blood Screening Testing
Research Application
Forensic Application

By Geography

North America
U.S.
Canada
Mexico
Europe
U.K.
Germany
France
Asia Pacific (APAC)
Japan
China
India
Middle East & Africa (MEA)
South Africa
UAE
Saudi Arabia
South & Central America (SCAM)
Brazil

Interested in purchasing this Report? Click here @ https://www.theinsightpartners.com/buy/TIPHE100000817/?openpr-10225

Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are committed to provide highest quality research and consulting services to our customers. We help our clients understand the key market trends, identify opportunities, and make informed decisions with our market research offerings at an affordable cost.
We understand syndicated reports may not meet precise research requirements of all our clients. We offer our clients multiple ways to customize research as per their specific needs and budget

This release was published on openPR.